ArticleFEBS open bio2018
Plasma anti-BIRC5 IgG may be a useful marker for evaluating the prognosis of nonsmall cell lung cancer.
Huan Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papercites it
ArticleFEBS open bio2018
Huan Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.